ROCKWELL MEDICAL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $14.92M.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $8.00M.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2017-12-31 was $7.50K.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for fiscal 2022 was $14.92M.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for fiscal 2018 was $21.94M, a 17647.10% increase from fiscal 2017.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for fiscal 2017 was $123.60K, a 54.19% increase from fiscal 2016.
- ROCKWELL MEDICAL, INC. stock issued during period, value, new issues for fiscal 2016 was $80.16K, a 98.06% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $14.92M 10-K · filed 2024-03-21 | |
| 2022-06-30 | $14.92M 10-Q · filed 2023-11-14 | |
| 2020-03-31 | $8.00M 10-Q · filed 2021-05-17 | |
| 2018-12-31 | $21.94M 10-K · filed 2019-03-18 | |
| 2017-12-31 | $7.50K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $123.60K 10-K · filed 2019-03-18 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $80.16K 10-K · filed 2018-03-15 |
| 2016-09-30 | $2.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.64M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.66M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $77.25K 10-Q · filed 2016-05-10 | $3.29M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $4.13M 10-K · filed 2018-03-15 |
| 2015-09-30 | $23.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $70.51M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $633.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $71.08M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $918.88K 10-Q · filed 2015-05-07 | $71.01M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $68.93M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $71.14M 10-K · filed 2017-03-15 |
| 2014-09-30 | $593.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.38M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $567.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $1.94M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.04M 10-Q · filed 2014-05-12 | $39.32M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $170.88K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $50.43M 10-K · filed 2016-02-29 |
| 2013-09-30 | $161.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $50.32M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $37.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $50.16M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $12.15M 10-Q · filed 2013-05-08 | $12.15M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $58.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $16.25M 10-K · filed 2015-03-03 |
| 2012-09-30 | $3.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $16.64M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$61.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $16.73M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $16.25M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $451.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $719.48K 10-K · filed 2014-03-07 |
| 2011-09-30 | $84.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | |
| 2010-12-31 | $90.45K 10-K · filed 2013-03-18 | |
| 2009-12-31 | $16.80M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |